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Abstract 
Aims: Core needle biopsy (CNB) in some clinical circumstances may be the only 
source of material from cancer tissue available for diagnostic purposes. The volume 
of tissue available in a CNB specimen is low and opportunities for research use can 
therefore be limited. The Tissue microarray (TMA) principle, if applied to the use 
of CNB specimens, could facilitate research studies in circumstances where only 
CNB samples are available. However, various challenges are expected in applying 
such a technique in CNB which has limited its use in research. We have conducted a 
systematic review of the literature on this subject. 
Methods and Results: A systematic search was carried out using CINAHL, EMBASE, 
Cochrane library and MEDLINE identifying studies which have primarily developed 
methods for constructing TMAs from CNB. Eight studies were found to meet the 
inclusion criteria; six of these employed the vertical rearrangement technique and 
two used multiple layers of biopsy tissue. Representation of the CNB was 
significantly influenced by the quantity of tumour cells present on the original 
biopsy and the degree of heterogeneity of biomarker expression.  
Conclusion: Technologies have been developed to enable construction of TMAs 
from CNB. However, challenges remain to improve amplification and 
representation. 
Keywords: Core needle biopsy, tissue microarrays, biopsy TMA, CNB TMA  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Introduction: 
In some clinical circumstances surgery may not be the preferred form of initial or 
primary therapy for breast cancer and a core needle biopsy (CNB) specimen will be 
the only available material from cancer tissue for diagnostic and research 
purposes. The volume of tissue and tumour in CNB specimens is far lower than 
tumour samples obtained from surgically resected specimens which significantly 
reduces opportunities for tissue based biological research studies. Methods to 
support biological studies in these clinical circumstances are clearly needed, for 
example to identify and validate the role of improved predictive biomarkers of 
therapy efficacy. Non-operative therapy, typically systemic therapy, is used in 
metastatic setting, as a neoadjuvant therapy to down-stage the disease prior to 
surgery, and as an alternative therapy to surgery, particularly in patients with co 
morbidities. For instance, about 40% of older women (>70 years) with early-stage 
breast cancer receive non-operative therapy, in the form of primary endocrine 
therapy (1-3), because they refuse or are unfit/frail due to concomitant co-
morbidities.   
Numerous published studies indicate high levels of concordance in biological 
characteristics observed between CNB and subsequent surgical excision or excision 
biopsy (4-8). A meta-analysis carried out by Li et al, (2012) indicated high 
correlation in such key biomarkers of breast cancer biology including oestrogen 
receptor (ER), progesterone receptor (PR) and human epidermal receptor (HER)2 
(6). Similar findings were seen in the estimation of Gleason score in prostate 
cancer patients (9, 10). Given such evidence for high concordance between CNB 
and surgical specimens, analysis of detailed biomarker expression in tissue 
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obtained by CNB would have great research potential. Although CNB provides 
enough tissue material for initial diagnosis, detailed profiling of the tumour 
requires a larger volume of tissue, which usually necessitates the use of tissue 
derived from surgical specimens. Therefore, if CNB were to be used for achieving 
this purpose, a technique that can maximise the utility of available tissue are 
required. Tissue microarray (TMA) techniques have been developed, for the 
purpose of high throughput immunohistochemical profiling of large cohorts of cases 
using limited amounts of tumour tissue (11). In addition it allows the analysis and 
evaluation of tissue-based assays in an efficient, cost-effective and uniform 
manner (12, 13). 
The length and thickness of the tissues obtained by CNB makes the conventional 
TMA method developed by Kononen et al, (1998) inappropriate for achieving the 
same objective using CNB. The small diameter of the biopsy material makes 
horizontal embedding less effective in amplifying the number of possible sections. 
Moreover, the biopsy diameter is often eroded after sectioning for initial diagnosis, 
thus, only a few sections would become obtainable. 
The current use of CNB is usually restricted to diagnostic purposes. Therefore, 
optimising a method for constructing TMAs from CNB presents an opportunity for 
researchers to profile tumours using a scarce source of tissue. On the other hand, 
given the potential technical challenges in such construction, it would be 
necessary to review the literature to identify and critically appraise different 
methods employed for that purpose. 
This study aimed to systematically review the literature for studies which had 
explored the technology of constructing TMAs from paraffin-embedded CNB and 
critically analyse their results. 
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Methods and search strategy 
The review of literature was carried out and presented following the Preferred 
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guideline (14). 
Electronic searches were used to review the literature for related studies. The 
studies were screened for their titles. The abstracts were then evaluated to 
determine the studies that would fit the selection criteria, and finally, full articles 
of the eligible studies were reviewed. 
 Electronic searches and information source 
A comprehensive search was carried out using CINAHL, EMBASE, Cochrane library 
and MEDLINE. The references of the studies were also screened for any other 
relevant studies. 
 Keywords 
Key words used for electronic search were identified using Medical Subject 
Headings (MeSH), including; “tissue microarrays AND core needle biopsy“, 
“construction AND tissue microarrays AND core needle biopsy“, “tissue microarrays 
AND needle biopsy“ and “tissue micro arrays AND core needle biopsy“. 
 Inclusion criteria 
Primary studies which developed methods for constructing TMAs from paraffin-
embedded CNB were included. The search was restricted to work published in 
English language and between 1998 – January 2015. 
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 Exclusion criteria 
Studies utilising a conventional approach to constructing TMA blocks, as described 
by Kononen et al (1998), were excluded.  
 Type of tissue 
Only CNB obtained from human tissues was considered. 
 Outcome measures 
Primary outcome: 
The primary objective was to evaluate methods for construction of TMAs from 
CNB. 
Secondary outcomes: 
The review also: 
• evaluated representativity (homogeneity, antigenicity and morphology) of 
tissue obtained from TMA blocks based on CNB; 
• investigated the number of obtainable sections; and  
• investigated the density of cores per block. 
Results 
The search databases and the number of studies associated with identified 
keywords are summarised in Table 1. Figure 1 shows a flow chart illustrating 
different phases of the systematic review.  Finally, a summary of the outcome 
measures is given in Table 2. 
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 Description of included studies 
Eight studies were found to meet the inclusion criteria (Table 2). Jhavar et al 
(2005) and Datta et al (2005) were the earliest to have published methods for 
construction of TMAs from CNB (15, 16). Their methods used the most 
representative area of the biopsy and re-arranged it vertically in the recipient TMA 
block. Jhavar’s method was later modified by McCarthy et al (2009), in terms of 
performing extraction biopsy from the donor block and the number of cores which 
could be included in the recipient block (17). Later, McCarthy et al (2011) utilised 
a manual arrayer for the purpose of producing high-density TMA blocks (18). Vogel 
and Bultmann (2010) and Fridman et al (2011) applied similar principles used by 
Jhavar et al (2005) with several modifications; this led to an increase in the 
number of TMA cores (19, 20). Furthermore, Fridman et al (2011) utilised all the 
tissue available from biopies whereas others limited the tissue selection to those 
enriched for tumour cells. As an alternative to the vertical re-arranging technique, 
Kishen et al (2011) and  Komiya et al (2013) employed techniques which included 
embedding multiple layers of horizontal representative segments of the biopsy into 
the recipient TMA block (21, 22). However, there is a distinct difference between 
the two techniques, where Kishen et al (2011) arranged the multiple layers one 
over the others, whereas Komiya et al (2014) arranged the layers on a single line.  
 Method for constructing TMAs from CNB 
Developed methods for constructing TMAs from CNB consist of two steps; 
extracting the biopsy from the donor block and integrating the extracted biopsy 
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within the recipient TMA block (Figure 2). However, for the purpose of ensuring an 
accurate positioning of biopsy segments within the recipient block and increasing 
the number of cores included in the TMA block, some techniques included an 
intermediate step that involved vertical embedding biopsies into an intermediate 
block. 
Jhavar et al (2005) started by cutting paraffin blocks to obtain a segment of cubic 
wax containing the biopsy, which was arranged in steel mould holding the biopsy in 
a vertical position. McCarthy et al (2009) modified the method of Jhavar et al 
(2005) in two aspects; first, by using pre-designed knives for extracting the 
biopsies of consistent length from the donor block; and second, by utilising a 
rubber template to design the recipient TMA block. These modifications allowed 
the construction of a TMA block with an extra capacity for cores and to allow easy 
extraction of tissue from the donor blocks. A further modification to the method 
used by Jhavar et al (2005) was performed by McCarthy et al (2011) and aimed to 
construct high-density TMA blocks. They used a manual tissue arrayer to punch and 
transfer biopsies from a pre-constructed intermediate block into the recipient 
block. The intermediate block was made in accordance with the method of Jhavar 
et al (2005) used originally for constructing the TMA block. 
Datta et al (2005) used un-fragmented biopsy segments. After extracting the 
biopsy, from the donor block using a scalpel, it was embedded in a pre-designed 
template in order to reform wax around the biopsy in a cylindrical shape. Biopsies 
were then transferred into the TMA blocks which were designed using a manual 
arrayer. As an alternative to extracting the biopsy from the donor block by scalpel, 
Vogel and Bultmann (2010) used a skin biopsy punch to obtain tissues enriched with 
tumour cells from the donor block. Their method included melting wax around 
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extracted tissue on a hot plate at 65 0C prior to transferring it to the TMA block. 
Studies utilising vertical rearrangement techniques were found to integrate tissue 
cores within the TMA block either by annealing the TMA or melting the TMA blocks 
and subsequent cooling it. 
Fridman et al, (2011) utilised a method where case selection was limited by the 
presence of a minimum of 30% of tumour cells in the biopsy. Their method included 
melting the original wax block, then staining the tissue cores with Eosin for better 
visulisation of the extracted tissue segment. Following this, each biopsy was 
fragmented into equal parts and re-embeded vertically in an intermediatary block. 
A manual arrayer was then used to transfer cores from the intermediatary block to 
the TMA block. 
Kishen et al (2011) applied a multiple-layer approach for making a biopsy TMA 
block which included embedding two segments of a biopsy (2mm each) on top of 
the other. The tissue used was confirmed microscopically to be rich in tumour cells 
prior to making the TMA block. 
Komiya et al (2013) started with cutting a thick section (30µm) from the donor 
block, then segments rich in tumour with size of 3mm were dissected from the 
section and arranged in line on a paraffin sheet of 100-µm thickness. Both tumour 
segments and paraffin sheet were rolled up into cylindrical reels. The cylindrical 
reels were then divided into sections and transferred into a pre-designed recipient 
block. 
 Representation of tissue obtained from the biopsy TMA block 
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Representation here refers to three aspects, namely, homogeneity between cores 
obtained from different biopsies of each patient, preservation of antigenicity and 
morphology of the original tissue. 
Jhavar et al (2005) found that antigenicity was fully preserved in tissue obtained 
from prostate CNB, where their investigation included staining tissue obtained 
from 123 individuals known to have prostate cancer. Antigenicity was investigated 
by evaluating three markers used for routine diagnosis, namely, low molecular 
weight keratin (CAM5.2), high molecular weight keratin (LP34) and prostate 
specific antigen (PSA). Similar findings were reported by Fridman et al (2011) who 
stained the produced sections with high-molecular weight cytokeratin (HMWCK), 
PIN-cocktail (p63+p504S), and PSA. Their work demonstrated that morphological 
and immunohistochemical chractaristics of original tumour CNB were maintained in 
TMA format.  
Datta et al (2005) used three cores rich in prostatic carcinoma cells from each 
individual CNB in order to provide a better estimation of protein expression. 
Seventeen sets of CNB and the corresponding radical prostatectomy specimens 
were stained for Ki67 antigen to investigate concordance between the two types of 
specimen and demonstrated an estimated correlation coefficient (r) of 0.4994 
(p=0.04). 
A tumour detection rate of 66-79% was achieved from TMA blocks constructed from 
CNB obtained from two series of prostate cancer patients (n=303) using the 
method described by McCarthy et al (2009). 
Vogel and Bultmann (2010) reported a high concordance between sections obtained 
from biopsy TMAs, excision biopsy and mastectomy specimens, in terms of HER2 
status in breast cancer. Investigations included using immunohistochemistry (IHC), 
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fluorescence in situ hybridisation (FISH) and automated brightfield double in situ 
hybridisation (BDISH) techniques. Results of IHC showed minor variations between 
different tissue types, whereas FISH and BDISH produced identical estimates of 
ErbB-2 gene amplification. 
Komiya et al (2013) demonstrated the representativity of CNB in TMAs by showing 
the prognostic value of Ki67, p53 and bcl-2 in prostate cancer based on the 
correlation between the results of IHC of these biomarkers and survival data of 58 
patients. 
 Number of cores and obtainable sections 
The capacity of a TMA block to include biopsy samples depends on the diameter of 
cores and distance between cores used. For instance, Jhavar et al (2005) who 
included the integration of biopsy and surrounded wax with the TMA block, 
produced a smaller number of cores that could be inoculated in the final TMA 
block. On the other hand, Vogel and Bultmann (2010) managed to include a large 
number of samples by removing the paraffin surrounding the biopsy segments. In 
addition, methods such as that from McCarthy et al (2011), which used a manual 
arrayer, were found to create a TMA block with higher capacity. This review 
indicates that the number of TMA cores ranged from 20 to 187 per TMA block.  
Methods for constructing TMA from CNB were found to have standardised CNB 
length of 3 to 4-mm. The number of obtainable representative sections was 
influenced directly by the amount of tumour cells present in the original biopsy. 
The thickness of sections used for IHC staining ranged between 3 and 5-µm (15-21).  
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Discussion 
The length and thickness of donor CNB was found to influence successful tissue 
extraction from the donor block and the integration of the cores within a recipient 
TMA block. The conventional method for constructing TMAs developed by Kononen 
et al (1998) has been limited by the need for relatively large amounts of tissue 
(11). The literature review indicates two approaches for use of CNB in TMA 
construction, namely, vertical re-arranging and a multiple layer approach utilised 
to ‘amplify’ tissue.   
An embedded biopsy with multiple fragments with surrounding wax would preserve 
the original structure of the biopsy. In addition, transferring biopsies with their 
surrounding wax would be easier and safer to maintain tissue structure than 
handling the biopsy itself. Moreover, an advantage of this method is to have better 
integration with the TMA block as wax surrounding the biopsy would easily anneal 
to the TMA block. Nevertheless, obtaining a biopsy from the donor block with 
surrounding paraffin would result in a lower number of cores being included in a 
final recipient block due to the wider area required. However, using a pre-designed 
tool to extract the biopsy in order to reduce the amount of paraffin surrounding 
the biopsy might improve the capacity of the TMA block to include more cores. A 
method for supporting a higher density TMA block includes using the use of a 
manual or automated arrayer for taking cores from the CNB. The limitation of this 
practice occurs with non-straight embedded cores or a slightly deviate biopsy from 
the vertical position; punching biopsies from donor blocks with such defects can 
result in less tissue being transferred into the recipient block. 
Extraction procedures involving the melting of the whole donor block helps achieve 
a straighter biopsy although the accuracy in re-orientating the original embedded 
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biopsy might be lost, leading to the possible misplacement of the pre-selected 
area rich in tumour cells. Instead of melting the whole block, extracting and 
melting the segment rich in tumour cells would avoid destroying the original 
material and help re-form and integrate the biopsy within the TMA block. 
Biopsies can sometimes contain a small amount of tumour cells (less than 4mm) 
which is not enough to be embedded vertically on the TMA block. Alternatively, in 
such circumstances, multiple-layers can be extracted from CNB biopsies and 
embedded one over the other. For this method TMA cores with the required length 
are therefore needed to produce a reasonable number of sections. However, 
stratified cores might contain intra-layer gaps leading to sections without 
representative tissue. Embedding multiple-layers in parallel or in-line on the 
surface of the recipient blocks would not help to amplify material from these 
blocks as the depth of tissue on sections will be similar to the thickness of original 
biopsies. 
Integration of the biopsies with its surrounding wax in the recipient block is a 
critical step of constructing the CNB TMA, as it is associated directly with biopsy 
orientation and quality of the section.  The techniques reviewed herein are found 
to apply two methods for integrating biopsies with surrounding wax, namely; i) 
Softening the recipient block, and/or ii) Melting the whole recipient block and re-
solidifying it. Although the softening method clearly helps to even the surface of 
the recipient block, this method would not ensure that transferred cores into the 
recipient block are completely annealed with the surrounding wax. One of the 
advantages of melting the donor block compared to the softening method is having 
perfectly integrated tissue with the surrounding wax. However, orientation of the 
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tissues within the recipient block is still an issue, and further work should focus on 
preserving tissue during integration step.  
It is important that sections obtained from biopsy TMAs represent the tumour 
characteristics of the whole tumour. Issues seen with "the standard method by 
Kononen et al. (1998)" such as intra-tumour heterogeneity might affect the 
assessment of tumour biology. For instance, the proliferation marker Ki67 
expression has shown considerable heterogeneity between different tumour areas 
(23, 24). Researchers developing TMAs have considered two technical strategies to 
avoid misrepresentation of the original tumour result due to small TMA cores, 
namely, ensuring a proper core diameter and the number of cores from each 
tumour case. 
The diameter of tissue taken by CNB usually ranges between 1.2 and 2.5-mm. 
Moreover, most studies that have constructed biopsy TMA blocks used complete 
cross sections of the biopsy. An extensively sectioned biopsy for initial tumour 
diagnosis might have smaller tissue spots. Singh et al (2007) suggested that fewer 
tumour cells available in TMA sections led to reduced representativity of the 
section and adversely affected the reliability of biopsy TMAs (25). Intra-tumour 
variations in biomarker expression among different tumour cells could result in 
reduced concordance between tissues from CNB and surgical specimens in terms of 
protein expression. For conventional TMAs, sampling strategy proves that three 
cores or more would properly represent the whole tumour tissue and reduce error 
associated with tumour heterogeneity (26-28). Datta et al (2005) investigated the 
optimal number of cores from each individual biopsy for better representation of 
the whole tumour in patients with prostate cancer, demonstrating that tumour 
biology could be accurately estimated using three core biopsies from each patient 
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(16). However, the number of cores per block depends on the degree of biomarker 
expression heterogeneity. It is also important to mention that there are situations 
where CNB should not be subjected to harvesting for TMA. Small invasive tumour 
tissue within the core or extensively sectioned CNB for initial tumour diagnosis 
with the potential of tumour depletion can be considered as a contraindication to 
TMA. This is to ensure preservation of diagnostic core material for subsequent 
review whenever needed particularly in relatively recent cases.  Another 
contraindication to CNB TMA is the lack of representation of the index invasive 
tumour such as CNBs from invasive carcinoma that contain pure ductal carcinoma 
in situ (DCIS),DCIS associated with microinvasion, or tiny invasive tumour tissue 
that are unlikely to be presented on TMA cores.  
Conclusion 
Constructing TMAs from CNB requires modification of the conventional 
methodology. Further developments are required to improve amplification of tissue 
from the biopsy. Owing to the issue of tumour heterogeneity as identified in the 
studies reviewed, further work should also focus on enhancing the representativity 
of tissues obtained from biopsy TMAs. 
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Table 1:Summary of a number of studies identified for different keywords and 
databases. 
Database Keywords
Number of articles 
found
CINAHL
Tissue microarrays AND core needle biopsy 0
Construction AND Tissue microarrays AND core 
needle biopsy 0
Tissue microarrays AND needle biopsy 0
Tissue micro array AND core needle biopsy 0
Cochrane 
library
Tissue microarrays AND core needle biopsy 2
Construction AND Tissue microarrays AND core 
needle biopsy 0
Tissue microarrays AND needle biopsy 2
Tissue micro array AND core needle biopsy 0
MEDLINE
Tissue microarrays AND core needle biopsy 20
Construction AND Tissue microarrays AND core 
needle biopsy 5
Tissue microarrays AND needle biopsy 58
Tissue micro array AND core needle biopsy 3
EMBASE
Tissue microarrays AND core needle biopsy 3
Construction AND Tissue microarrays AND core 
needle biopsy 0
Tissue microarrays AND needle biopsy 45
Tissue micro array AND core needle biopsy 0
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Table 2: Summary of characteristics of included studies. 
Num
ber
Author
s
Tum
our 
site
Numbe
r of 
cores/
TMA 
block
Core 
Measu
res
No. of 
obtainab
le 
sections 
(thickne
ss)
Tissu
e loss Representativity Concordance
1
Datta 
et al, 
(2005)
Prost
ate 60
1.5-
mm Ø, 
2-mm
50-150 
(5-µm) -
M a r k e r :  K i - 6 7 , 
assessed using IHC. 
K i - 6 7 w a s o v e r 
estimated on core 
n e e d l e b i o p s y 
compared to radical 
prostatectomy; the 
coefficient correlation 
between two sources 
o f t i s s u e w a s 
(r=0.4994, P=0.04).
2
Jhavar 
et al, 
(2005)
Prost
ate 45 4-mm
90-100 
(4-µm) 9%
M a r k e r :  L o w 
m o l e c u l a r w e i g h t 
keratin (CAM5.2), high 
m o l e c u l a r w e i g h t 
k e r a t i n ( L P 3 4 ) , 
p r o s t a t e s p e c i f i c 
marker (PSA) and 
H&E, assessed using 
IHC. 
Antigenicity: 100% 
preserved.
-
3
McCart
hy et 
al, 
(2009)
Prost
ate
Maximu
m 72 4-mm - -
Marker: p63/AMACR, 
Ki-67 and Hif1-α . 
Gene amplification: 
ERG gene status was 
invest igated us ing 
FISH. 
Cancer detection 
rate: 66-79% 
No d i f f e r e n c e i n 
marker expression 
w a s s e e n w h e n 
compared with an old 
method (Jhavar et al, 
2005).
4
Vogel 
and 
Bultma
nn, 
(2010)
Brea
st
Maximu
m 187
1.4-
mm Ø, 
4-mm
600 (3-
µm)
1 to 
2% of 
tissue 
rollin
g or 
foldin
g
M a r k e r : H E R 2 , 
assessed using IHC. 
Gene amplification: 
E r b B - 2 , a s s e s s e d 
u s i n g F I S H a n d 
BDISH.
- Concordance was 
investigated between 
sect ions obtained 
from core needle 
b i o p s y a n d 
m a s t e c t o m y 
specimen.  
- IHC results showed 
minor variations. 
- FISH and BDISH 
showed i den t i c a l 
estimate of ErbB-2 
gene amplification.
5
McCart
hy et 
al, 
(2011)
Prost
ate
Maximu
m 104
1.5-
mm Ø, 
4-mm
- - - -
6
Kishen 
et al, 
(2011)
Brea
st
18
0.6-
mm Ø, 
4-mm
More 
than 
100
- - -
7
Fridma
n et al, 
(2011)
Prost
ate -
0.5 to 
0.6-
mm Ø, 
3 to 4-
mm
80-100 
(4-µm)
No 
eviden
t  of 
tissue 
loss
Marker:   High-
molecular weight 
cytokeratin (HMWCK), 
PIN-cocktail 
(p63+p504S), and 
Prostate specific 
marker (PSA), 
assessed using IHC.
-
8
Komiya 
et al, 
(2013)
Prost
ate
20
3-mm 
Ø, 3-
mm
>100 
(4-µm)
-
Marker:  Ki-67, p53 
a n d b c l - 2 w e r e 
assessed using IHC. -
!  18
 (IHC) Immunohistochemistry; (FISH) Fluorescence in situ hybridization; (BDISH) Bright field in 
situ hybridisation.  
!  19
Titles and legends to figures 
Figure 1 Summary of the search process and results of literature 
review of construction of tissue microarrays from core needle 
biopsy. 
Figure 2  Approaches for constructing tissue microarrays from core   
 needle biopsy. 
!  20
